These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14747616)

  • 21. Redox regulation of protein-tyrosine phosphatases.
    den Hertog J; Groen A; van der Wijk T
    Arch Biochem Biophys; 2005 Feb; 434(1):11-5. PubMed ID: 15629103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The oxidative mechanism of action of ortho-quinone inhibitors of protein-tyrosine phosphatase alpha is mediated by hydrogen peroxide.
    Bova MP; Mattson MN; Vasile S; Tam D; Holsinger L; Bremer M; Hui T; McMahon G; Rice A; Fukuto JM
    Arch Biochem Biophys; 2004 Sep; 429(1):30-41. PubMed ID: 15288807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective regulation of hydrogen peroxide signaling by receptor tyrosine phosphatase-alpha.
    Hao Q; Rutherford SA; Low B; Tang H
    Free Radic Biol Med; 2006 Jul; 41(2):302-10. PubMed ID: 16814111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A one-step method to identify MAP kinase residues involved in inactivation by tyrosine- and dual-specificity protein phosphatases.
    Tárrega C; Pulido R
    Anal Biochem; 2009 Nov; 394(1):81-6. PubMed ID: 19583964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of protein tyrosine phosphatase 1B in Ras signaling.
    Dubé N; Cheng A; Tremblay ML
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1834-9. PubMed ID: 14766979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A chemical model for redox regulation of protein tyrosine phosphatase 1B (PTP1B) activity.
    Sivaramakrishnan S; Keerthi K; Gates KS
    J Am Chem Soc; 2005 Aug; 127(31):10830-1. PubMed ID: 16076179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic approaches to studying protein tyrosine phosphatases.
    Liang F; Kumar S; Zhang ZY
    Mol Biosyst; 2007 May; 3(5):308-16. PubMed ID: 17460790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible oxidation of the membrane distal domain of receptor PTPalpha is mediated by a cyclic sulfenamide.
    Yang J; Groen A; Lemeer S; Jans A; Slijper M; Roe SM; den Hertog J; Barford D
    Biochemistry; 2007 Jan; 46(3):709-19. PubMed ID: 17223692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a modified in-gel assay to identify protein tyrosine phosphatases that are oxidized and inactivated in vivo.
    Meng TC; Hsu SF; Tonks NK
    Methods; 2005 Jan; 35(1):28-36. PubMed ID: 15588983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of protein-tyrosine phosphatases by in-gel assays.
    Markova B; Gulati P; Herrlich PA; Böhmer FD
    Methods; 2005 Jan; 35(1):22-7. PubMed ID: 15588982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5,5-Dimethyl-3-(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-3,5,6,7-tetrahydro-1H-indole-2,4-dione, a potent inhibitor for mammalian elongase of long-chain fatty acids family 6: examination of its potential utility as a pharmacological tool.
    Shimamura K; Kitazawa H; Miyamoto Y; Kanesaka M; Nagumo A; Yoshimoto R; Aragane K; Morita N; Ohe T; Takahashi T; Nagase T; Sato N; Tokita S
    J Pharmacol Exp Ther; 2009 Jul; 330(1):249-56. PubMed ID: 19359527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems.
    Baranczewski P; Edlund PO; Postlind H
    J Pharm Biomed Anal; 2006 Mar; 40(5):1121-30. PubMed ID: 16307862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein tyrosine phosphatases in the nervous system.
    Naegele JR; Lombroso PJ
    Crit Rev Neurobiol; 1994; 9(1):105-14. PubMed ID: 8828006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gold(I)-mediated inhibition of protein tyrosine phosphatases: a detailed in vitro and cellular study.
    Krishnamurthy D; Karver MR; Fiorillo E; Orrú V; Stanford SM; Bottini N; Barrios AM
    J Med Chem; 2008 Aug; 51(15):4790-5. PubMed ID: 18605719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate.
    Lee H; Xie L; Luo Y; Lee SY; Lawrence DS; Wang XB; Sotgia F; Lisanti MP; Zhang ZY
    Biochemistry; 2006 Jan; 45(1):234-40. PubMed ID: 16388599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural compounds as a source of protein tyrosine phosphatase inhibitors: application to the rational design of small-molecule derivatives.
    Ferreira CV; Justo GZ; Souza AC; Queiroz KC; Zambuzzi WF; Aoyama H; Peppelenbosch MP
    Biochimie; 2006 Dec; 88(12):1859-73. PubMed ID: 17010496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. trans-Beta-nitrostyrene derivatives as slow-binding inhibitors of protein tyrosine phosphatases.
    Park J; Pei D
    Biochemistry; 2004 Nov; 43(47):15014-21. PubMed ID: 15554709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Covalent inhibition of protein tyrosine phosphatases.
    Ruddraraju KV; Zhang ZY
    Mol Biosyst; 2017 Jun; 13(7):1257-1279. PubMed ID: 28534914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells.
    Boivin B; Zhang S; Arbiser JL; Zhang ZY; Tonks NK
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):9959-64. PubMed ID: 18632564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redox regulation of protein tyrosine phosphatases: methods for kinetic analysis of covalent enzyme inactivation.
    Parsons ZD; Gates KS
    Methods Enzymol; 2013; 528():129-54. PubMed ID: 23849863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.